MNBTD
GSK icon

Moody National Bank Trust Division’s GSK GSK Stock Holding History

Moody National Bank Trust Division’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$536K Sell
10,227
-11
-0.1% -$582 0.04% 336
2026
Q1 		$565K Sell
10,238
-802
-7% -$43.5K 0.05% 323
2025
Q4 		$541K Buy
11,040
+705
+7% +$32.9K 0.05% 332
2025
Q3 		$446K Sell
10,335
-1,191
-10% -$46.5K 0.04% 360
2025
Q2 		$443K Buy
11,526
+461
+4% +$17.6K 0.04% 353
2025
Q1 		$429K Buy
11,065
+473
+4% +$17.3K 0.04% 361
2024
Q4 		$358K Sell
10,592
-13
-0.1% -$468 0.04% 383
2024
Q3 		$434K Buy
10,605
+949
+10% +$38.8K 0.05% 361
2024
Q2 		$372K Sell
9,656
-400
-4% -$16.8K 0.03% 353
2024
Q1 		$431K Sell
10,056
-2,108
-17% -$86.9K 0.03% 348
2023
Q4 		$451K Sell
12,164
-7,101
-37% -$255K 0.04% 351
2023
Q3 		$698K Hold
19,265
– – 0.05% 307
2023
Q2 		$687K Buy
19,265
+380
+2% +$13.6K 0.05% 297
2023
Q1 		$672K Buy
18,885
+203
+1% +$7.1K 0.06% 281
2022
Q4 		$656K Buy
+18,682
New +$622K 0.06% 275
2022
Q3 		– Sell
-8,985
Closed -$489K – 586
2022
Q2 		$489K Sell
8,985
-2,786
-24% -$154K 0.05% 291
2022
Q1 		$641K Sell
11,771
-58
-0.5% -$3.15K 0.02% 256
2021
Q4 		$652K Sell
11,829
-32,568
-73% -$1.69M 0.02% 257
2021
Q3 		$2.12M Sell
44,397
-80
-0.2% -$4.02K 0.03% 226
2021
Q2 		$2.21M Buy
44,477
+476
+1% +$22.9K 0.05% 228
2021
Q1 		$1.96M Buy
44,001
+203
+0.5% +$9.21K 0.05% 229
2020
Q4 		$2.02M Buy
43,798
+982
+2% +$45.1K 0.05% 214
2020
Q3 		$2.01M Hold
42,816
– – 0.06% 200
2020
Q2 		$2.18M Buy
42,816
+9,941
+30% +$510K 0.07% 193
2020
Q1 		$1.56M Hold
32,875
– – 0.05% 200
2019
Q4 		$1.93M Hold
32,875
– – 0.05% 198
2019
Q3 		$1.75M Buy
32,875
+5,456
+20% +$281K 0.05% 198
2019
Q2 		$1.37M Hold
27,419
– – 0.04% 213
2019
Q1 		$1.43M Buy
27,419
+133
+0.5% +$6.65K 0.04% 215
2018
Q4 		$1.3M Buy
27,286
+406
+2% +$20K 0.04% 209
2018
Q3 		$1.35M Buy
+26,880
New +$1.37M 0.03% 217

Other funds holding GSK

MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Moody National Bank Trust Division's GSK Position: Q2 2026 in Review

Moody National Bank Trust Division reduced its GSK (GSK) stake by 0.11% in Q2 2026, selling an estimated $582 and leaving 10,227 shares worth $536K. The position accounts for 0.04% of the portfolio, ranked #336.

Moody National Bank Trust Division first reported a position in GSK in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.21M in Q2 2021. 410 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Moody National Bank Trust Division held 10,227 shares of GSK worth $536K as of Q2 2026.
  • Moody National Bank Trust Division sold 11 GSK shares in Q2 2026, an estimated $582.
  • GSK made up 0.04% of Moody National Bank Trust Division's portfolio in Q2 2026, its #336 holding.
  • Moody National Bank Trust Division first reported a position in GSK in Q3 2018 and has held it in 31 quarters since.
  • Moody National Bank Trust Division's GSK position peaked at $2.21M in Q2 2021.
  • 410 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.